Martin Hoenigl, n/a
Medical University of Graz, Department of Internal Medicine, Division of Infectious Diseases
Graz, Steiermark, Austria
Disclosure: Disclosure(s): Astellas: Grant/Research Support (); Gilead: Grant/Research Support (); NIH: Grant/Research Support (); Pfizer: Grant/Research Support (); Scynexis: Grant/Research Support ()
Matthias Egger, MD (he/him/his)
Research fellow
Medical University of Graz, Department of Internal Medicine, Division of Infectious Diseases
Graz, Steiermark, Austria
Disclosure: Disclosure(s): No financial relationships to disclose
Jon Salmanton-Garcia, n/a
PhD student
University Hospital Cologne, Cologne, Germany
Cologne, Nordrhein-Westfalen, Germany
Disclosure: Disclosure(s): No financial relationships to disclose
Philipp Koehler, n/a
Medical Doctor
University Hospital Cologne, Cologne, Germany
Cologne, Nordrhein-Westfalen, Germany
Disclosure: Disclosure(s): No financial relationships to disclose
Jean-Pierre Gangneux, n/a
CHU de Rennes, Rennes, France
Rennes, Bretagne, France
Disclosure: Disclosure(s): No financial relationships to disclose
Maiken C. Arendrup, DMSci, PhD, MD
Prof., Head of Unit
Statens Serum Institut
Copenhagen, Hovedstaden, Denmark
Disclosure: Disclosure(s): Chiesi, Gilead: Honoraria (); F2G, Cidara, Scynexis: Grant/Research Support ()
Tihana Bicanic, n/a
St Georges University Hospital, London, United Kingdom
London, England, United Kingdom
Disclosure: Disclosure(s): No financial relationships to disclose
Sevtap Arikan-Akdagli, n/a
Hacettepe University, Infectious Diseases and Clinical Microbiology, Ankara, Turkey
Ankara, Ankara, Turkey
Disclosure: Disclosure(s): No financial relationships to disclose
Oliver A. Cornely, Prof. Dr.
Prof.
University of Cologne, Faculty of Medicine and University Hospital Cologne
Cologne, Nordrhein-Westfalen, Germany
Disclosure: Disclosure(s): Abbott: Honoraria (); Abbvie: Advisor/Consultant (); Actelion: Board Member (); Al-Jazeera Pharmaceuticals: Honoraria (); Allecra Therapeutics: Board Member (); Amplyx: Advisor/Consultant (), Grant/Research Support (); Astellas: Honoraria (); Basilea: Advisor/Consultant (), Grant/Research Support (); Biocon: Advisor/Consultant (); Biosys: Advisor/Consultant (); BMBF: Grant/Research Support (); Cidara: Advisor/Consultant (), Board Member (), Expert Testimony (), Grant/Research Support (); CoRe Consulting: Stocks/Bonds (); Da Volterra: Advisor/Consultant (); DLR: Grant/Research Support (); DZIF: Grant/Research Support (); Entasis: Board Member (); EU Directorate-General for Resarch and Innovation: Grant/Research Support (); F2G: Grant/Research Support (); German Patent and Trade Mark Office: German patent (DE 10 2021 113 007.7) (); Gilead: Advisor/Consultant (), Grant/Research Support (); Grupo Biotoscana/United Medical/Knight: Honoraria (); Hikma: Honoraria (); IQVIA: Board Member (); Janssen: Board Member (); Matinas: Advisor/Consultant (), Grant/Research Support (); MedPace: Advisor/Consultant (), Grant/Research Support (); MedScape: Honoraria (); MedUpdate: Honoraria (); Menarini: Advisor/Consultant (); Merck/MSD: Grant/Research Support (), Honoraria (); Molecular Partners: Advisor/Consultant (); MSG-ERC: Advisor/Consultant (); Mundipharma: Grant/Research Support (); Mylan: Honoraria (); Noxxon: Advisor/Consultant (); Octapharma: Advisor/Consultant (), Grant/Research Support (); Paratek: Board Member (); Pardes: Advisor/Consultant (); Pfizer: Grant/Research Support (), Honoraria (); Projektträger Jülich: Grant/Research Support (); PSI: Advisor/Consultant (), Board Member (); Pulmocide: Board Member (); Scynexis: Advisor/Consultant (), Grant/Research Support (); Seres: Advisor/Consultant (); Shionogi: Board Member (); Wiley (Blackwell): Editor-in-Chief, Mycoses ()
ECMM Study Group, n/a
European Confederation of Medical Mycology
Basel, Basel-Stadt, Switzerland
Disclosure: Disclosure(s): No financial relationships to disclose